Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018642 · ClinicalTrials.gov registry record · NA
Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
NCT00018642: Completed NA study, sponsored by US Department of Veterans Affairs.
NCT00018642 is a NA study that has completed, run by US Department of Veterans Affairs. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00018642, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this research study is to determine whether a new drug for schizophrenia is better for the maintenance treatment than a standard drugs currently prescribed. The new medication is called quetiapine and it will be compared with a standard medication called haloperidol decanoate. The study will determine if quetiapine causes fewer problems than haloperidol with side effects such as stiffness and restlessness and whether it costs the VA more or less to treat patients with quetiapine. In addition, blood samples will be collected every three months to determine if certain chemicals in the blood can influence the outcome of the subjects' illness.
Interventions
- DRUG quetiapine
- DRUG haloperidol decanoate
Trial Details
| Field | Value |
|---|---|
| Start Date | 1997-04 |
| Est. Completion | 2002-03 |
| Phase | NA |
What the finished NCT00018642 record still lists
NCT00018642 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which quetiapine is the first listed.
NCT00018642 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00018642 about?
NCT00018642 is a clinical study titled "Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder". The purpose of this research study is to determine whether a new drug for schizophrenia is better for the maintenance treatment than a standard drugs currently prescribed. The new medication is called quetiapine and it will be compared with a standard medication called haloperidol decanoate. The stu...
What is the current status of trial NCT00018642?
This trial is currently completed. It is a NA study. The study started on 1997-04. Estimated completion is 2002-03.
What interventions are being tested in trial NCT00018642?
The interventions under investigation include: quetiapine (DRUG), haloperidol decanoate (DRUG).
Who is sponsoring clinical trial NCT00018642?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia